跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ROTATEQ SOLUCION ORAL
Approved
STANDARD
ROTATEQ SOLUCION ORAL
Merck Sharp & Dohme B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 8, 2022
Approval ID
817b5c454cfa7f27
Company
Merck Sharp & Dohme B.V.
Type
Standard
Approval Details
Approval Id
817b5c454cfa7f27
Drug Cima Aemps Name
ROTATEQ SOLUCION ORAL
Register Number
06348001IP4
Holder Company Name
Merck Sharp & Dohme B.V.
Marketing Company Name
Ecofar Productos S.L.
Holder Company Detail Path
/organization/merck-sharp-and-dohme-bv
Authorization Date
2022-11-08
Dosage Form
SOLUCIÓN ORAL
Dose
Desconocida
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Merck Sharp & Dohme B.V.
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Company Information
Pharmaceutical Company Name
Merck Sharp & Dohme BV
Country Name
Netherlands
Active Ingredients
ROTAVIRUS HUMANO SEROTIPO G2
2,8x10e6 UI
ROTAVIRUS HUMANO SEROTIPO G1
2,2x10e6 UI
ROTAVIRUS HUMANO SEROTIPO G3
2,2x10e6 UI
ROTAVIRUS HUMANO SEROTIPO G4
2x10e6 UI
ROTAVIRUS HUMANO SEROTIPO P1
2,3x10e6 UI
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 8, 2022
Approval ID
817b5c454cfa7f27
Type
Standard
Back to CIMA-AEMPS Approvals
ROTATEQ SOLUCION ORAL - CIMA-AEMPS Drug Approval Details